ArticleLife (Basel, Switzerland)2022

The Case for Clinical Trials with Novel GABAergic Drugs in Diabetes Mellitus and Obesity.

Ferenc A AntoniPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.